United Kingdom · Biopharma startup
United Kingdom · Resolution Therapeutics
Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
Funding reportedLast round: Series A
Follow Resolution Therapeutics and see its new rounds in your feed.Start following
What company datasets say Resolution Therapeutics raised
Funding, as reported
Reported in all38Min the source's currency
Rounds3
Last roundSeries A
Last round dateApr 2022
Investors listed2
Founders and team
From Resolution Therapeutics's own website: 14 on the team.
- Amir HefniCEO
- Amol KetkarChief Manufacturing and Technical Operations Officer
- Daniel KennedyChief Business Officer
- Lucy SingahChief Financial Officer
- Eli GilsohnVP, Intellectual Property & Technology Strategy
- Louise RoweVP, Operations
- Shazia PandorVP, People & Culture
- Alessio D'addabboAnalyst - Syncona
- Bill SymondsNon-Executive Director
- Edward HodgkinManaging Partner - Syncona
- Gonzalo GarciaPrincipal - Syncona
- Paul SekhriChair
- Prof. John CampbellDirector - TCAT Scottish National Blood Transfusion Service
- Prof. Jonathan FallowfieldChair of Translational Liver Research
Biopharma in United Kingdom
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Resolution Therapeutics in front of investors. Or tell us what we have wrong.